In FDA regulated health care life science manufacturing industry,
21 CFR Part 820 Quality System Regulation is
very important for good manufacturing practise for the medical device.
Engineering Change is an important topic. I would like to pen down my experiences before all faded away.
Engineering Change Order (ECO )
will trigger the following requirements:
(1) Input
Optimization Concept to elaborate the changes description/ benefits and
impacts.
(2) Release Engineering
Change Order (ECO ) to manufacturing plant.
(3) Document list changes
to have respective department representatives to review the changes impact on
R&D/LCM, GPS , SCM ,
PE , V&V, RA, etc.
(4) Change form
LCM (Life Cycle Management) instrumentation should be filled too.
If the ECO cannot be
released at the short period of time, a temporary deviation form can be raised,
for example: ANF - Approval /Notification
Form.
Most of the engineering changes are due to:
(1) Correction of the engineering drawings (be it drawing errors/discrepancy),
production documentation (update on assembly build instruction), BOM correction
(part quantities mismatch between the BOM and the exact usage on the production
line, for example the screws quantities, etc.), packing list updates.
(2) End of life (EOL) part proposed by the
vendor/manufacturer that leads to new MPN change. RoHS and REACH compliances
must be declared. Electrical characteristics shall be reviewed. Critical changes
like photomultiplier tube (PMT), rotor coupling, stepper motor will require
trial report and evaluation report for careful studies and comparison. Such
change will also impact the SP (Specification) document. It has DHF (Device
History File) impact.
DHF impacted changes will also required re-validation. It depends from the scope of the change and impact to the end results. Such change can also impact the application side (chemistry, reagents and assays).
DHF impacted changes will also required re-validation. It depends from the scope of the change and impact to the end results. Such change can also impact the application side (chemistry, reagents and assays).
There will be no
change in form, fit and functional.
FDA auditors always like to see such statement stated in the Engineering Change Order. It implies that you have gone through the changes carefully, thoroughly.
FDA auditors always like to see such statement stated in the Engineering Change Order. It implies that you have gone through the changes carefully, thoroughly.
(3) Escalated customer complaints (from Global Product
support) leads to investigation of the problem. Design change/ improvement will
eliminate or reduce the occur rate of the incidents. For example, the cable
bending for too long causes intermittent. It shall be replaced by higher class
of cable materials that can hold millions of bending cycles.
(4) Production software updates. User manual CD, software
updates (on the BOM level) or spare part changes, new spare part added into the
list.
(5) New OEM implementation. (Different label information and
cover colour for example).
(6) Cost reduction project. For example to reduce the instrument
48 hours burn in test to 8 hours run in test.
(7) Refurbish protocol update (for exhibition pool, demo
units)
(8) Production transfer, for example from California
to Malaysia .
The Production Release report must be assessed and completed then an Engineering
Change Order can be released accordingly.
No comments:
Post a Comment